Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-29

Clinical Trial Update: Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial investigating topical antioxidants for dry eye disease and diabetic retinopathy, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Adolfo Daniel Rodriguez-Carrizalez | Conditions: Dry Eye Syndromes, Diabetic Retinopathy | Phase 2 | Status: UNKNOWN